Sarepta Therapeutics | SRPT - 净收入



金融业
股票价格
USD
资产
USD 3.19B
现金及等价物
USD 571.15M
销售成本
USD 150.1M
流动资产
USD 2.22B
流动负债
USD 502.91M
债务
USD 1.04B
EBIT
USD 13.29M
EBITDA
USD 375.48M
员工
1.37K
EPS每股收益
USD 0.64
股本和储备
USD 1.53B
销售毛利
USD 251.15M
债务利息支出
USD 21.51M
利息收入
USD 7M
贷款资金
USD 847.62M
市值
USD 1.66B
净收入
USD 330.96M
营业费用
USD 387.96M
营业利润
USD 13.29M
普通股股本
USD 105.62M
PE价格收益
27.27
税前利润
USD -1.75M
销售收入
USD 401.3M
销售和管理费用
USD 107.6M
股票
USD 904.27M
贸易债权人
USD 50.98M
应收帐款人
USD 393.8M


净收入 更改 日
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Amgen USD 2.38B 556M 2026-06
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
Biogen USD 97.5M 222M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Daiichi Sankyo JPY 68.64B 18B 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
Incyte USD 585.6M 282.27M 2026-06
Insmed USD -13.24M 150.32M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Moderna USD -1.34B 517M 2026-03
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Novavax USD 17.53M 219.91M 2025-12
Pfizer USD -248M 2.94B 2026-06
PTC Therapeutics USD -2.81M 132.16M 2026-03
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR 343M 1.27B 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Tectonic Therapeutic USD -25.24M 6.02M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06